Welcome to Enabled Therapeutics, formerly known as Mercaptor. We are excited to share that all information on our website including our Capton intellectual property and approach is now managed by the founders of Enabled Therapeutics. This marks an exciting new phase in the development of Captons, and we look forward to advancing therapeutic solutions. All historical news below refers to Mercaptor, our former name.
Movers and Shakers: Mercaptor named as one of Biospace’s Movers and Shakers
BioSpace champions the Life Sciences industry as a digital hub for news and careers. This month, they have named Mercaptor Discoveries as one of their
Mercaptor Announces the Appointment of World-Renowned Neuropathologist Dr. Adriano Aguzzi to Scientific Advisory Board
Mercaptor announced today that Dr. Adriano Aguzzi, MD, PhD, is heading up the formation of its Scientific Advisory Board (SAB). Dr. Aguzzi is a world-renowned neuropathologist,
Mercaptor Proves Positive in Preclinical Proof of Concept (POC) in NIH-Funded Studies
Happy to share some more exciting news with you all! We have just published a press release to announce the exciting news about our Positive Preclinical
Sara Isbell profiled in Latina Style Magazine
Mercaptor CEO, Sara Isbell was profiled in Latina Style Magazine’s “Latinas in STEM” feature. Latina Style is a national publication with a mission of empowering
Team Mercaptor at Parkinson’s Moving Day
On May 6, 2018, Mercaptor Discoveries participated in our first Parkinson’s Moving Day, an annual fundraising walk event hosted by the Parkinson’s Foundation. Team Mercaptor
Mercaptor on Pace at Walk to Defeat ALS 2018
On April 28, 2018 Mercaptor Discoveries participated in its second Walk to Defeat ALS, an ALS Association event held in Sonoma County. Team Mercaptor Discoveries